NRX Pharmaceuticals (NRXP)

• Market cap: $58.2M
• 1 day: -5.91%
• 5 days: -13.03%
• 1 month: -21.59%
• 3 months: -26.07%
• 6 months: -39.83%
• Year to date: -30.77%
• 1 year: 72.5%
• 5 years: -98.64%
• 10 years: -97.84%
• Sector: Healthcare
• Industry: Biotechnology

About: NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.